Concepedia

M. Ziemen

MZ

15

Publications

2.4K

Citations

14

H-Index

1980

Active since

Affiliations

Sanofi (Germany)(Current)

University of Perugia

Oregon Health & Science University

Park Nicollet Clinic

Newcastle University

M. Ziemen is an author at Sanofi (Germany) specializing in medicine, diabetes, and metabolic syndrome.

Top concepts

Publications per year

1980–2018

15

Publications

15

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki‐Järvinen, A. Dressler, M. Ziemen · Diabetes Care · 2000 · 580 citations · Full text

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Matthew C. Riddle, Geremia B. Bolli, M. Ziemen et al. · Diabetes Care · 2014 · 359 citations

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)

Geremia B. Bolli, Matthew C. Riddle, Richard M. Bergenstal et al. · Diabetes Obesity and Metabolism · 2015 · 297 citations · Full text

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Hannele Yki‐Järvinen, Richard M. Bergenstal, M. Ziemen et al. · Diabetes Care · 2014 · 274 citations

, , +15

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Philip Home, Richard M. Bergenstal, Geremia B. Bolli et al. · Diabetes Care · 2015 · 219 citations · Full text

Rows per page

1–5 of 15